Skip to content
Canadian orders above $200 ship free · Dispatched from Canadian stock

Retatrutide side effects and results in studies

Wherever a cited study commented on tolerability, that wording is reproduced verbatim below. Human work on this scale does not pin down a safety profile.

Adverse events reported

EventAs reportedSource
The most common adverse events were gastrointestinal, dose-related and mostly mild to moderate.HumanJastreboff AM et al.
Discontinuation for adverse events was 2–5% with retatrutide and 0% with placebo.HumanBajaj HS et al.
Treatment-emergent adverse events were reported by 63% of participants on LY3437943, 60% on dulaglutide and 54% on placebo, with gastrointestinal disorders the most frequent.HumanUrva S et al.

Outcomes measured

No outcome data are tabulated yet.

What the studies don't show

None of that settles safety beyond the specific conditions of each trial. Confirming that the vial contains what the label states tells you nothing about whether the compound has any effect.